Disease Overview:Urticaria(URT)
Urticaria, commonly known as hives, is a transient, pruritic dermatologic condition characterized by evanescent, erythematous, and edematous wheals—often surrounded by a halo of erythema—resulting from mast cell–mediated dermal vascular permeability and sensory nerve activation. Acute urticaria typically resolves within six weeks and is frequently triggered by infections, medications (e.g., NSAIDs, antibiotics), or food allergens; chronic spontaneous urticaria (CSU), persisting beyond six weeks, involves complex immunopathogenic mechanisms—including autoantibodies against FcεRI or IgE—and requires thorough evaluation for underlying comorbidities such as thyroid autoimmunity or Helicobacter pylori infection. Diagnosis relies on clinical assessment, detailed history, and selective testing (e.g., autologous serum skin test, thyroid function panels, total IgE), while management follows a stepwise algorithm: second-generation H1-antihistamines at standard or up-titrated doses, followed by omalizumab for refractory CSU, with cyclosporine or montelukast reserved for select non-responders.
China offers distinct advantages in urticaria care: leading dermatology centers—such as Peking Union Medical College Hospital and Huashan Hospital—house nationally accredited Urticaria Excellence Units staffed by specialists trained in EAACI/GA²LEN guidelines and experienced in biologic therapy optimization. Advanced diagnostic platforms include automated basophil activation testing and high-sensitivity IgE quantification, complemented by real-world data from large-scale CSU registries. Clinical outcomes reflect this expertise: over 85% of omalizumab-treated CSU patients achieve complete symptom control within 12 weeks, per 2023 multicenter cohort studies. Treatment costs remain significantly lower than in the US or Western Europe—omalizumab courses average USD 2,400–3,600 versus USD 7,000–12,000 abroad—without compromising quality or regulatory compliance (NMPA-approved biologics only). As a dedicated medical tourism agency, we facilitate seamless international patient journeys: verifying hospital credentials, coordinating specialist consultations, providing itemized, all-inclusive pricing (consultation, diagnostics, treatment, accommodation), and assigning bilingual case managers for end-to-end logistical and clinical support—from visa assistance to post-discharge follow-up coordination.
Urticaria: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Urticaria (Dermatology)
Non-Surgical / Conservative / Medication Options
*Target Criteria:* Chronic spontaneous urticaria (>6 weeks), acute urticaria with persistent symptoms, or refractory cases unresponsive to first-line therapy.
- •First-Line Therapy (Antihistamines)
- *Cetirizine (10 mg/day)*: ¥20–¥45/month → $3–$6 - *Desloratadine (5 mg/day)*: ¥60–¥120/month → $8–$17
- •Second-Line Therapy (Updosed Antihistamines + Add-ons)
- *Montelukast (10 mg/day, adjunct)*: ¥45–¥85/month → $6–$12
- •Third-Line Biologic Therapy (Omalizumab)
- *Dosing:* 300 mg SC every 4 weeks (weight- and IgE-adjusted) - *Per dose:* ¥1,800–¥2,200 → $250–$310 - *Monthly cost (1–2 doses):* $250–$620
- •Diagnostic & Monitoring Fees (Per Episode)
- *Total IgE assay:* ¥120 → $17 - *Autoantibody panel (anti-TPO, anti-thyroglobulin, anti-FcεRIα):* ¥320 → $45 - *Complete blood count + ESR:* ¥150 → $21
Surgical / Procedural / Interventional Options
*No surgical or procedural interventions are indicated for urticaria.* Urticaria is an immune-mediated inflammatory skin disorder; no dermatologic surgery, laser, or invasive procedures are evidence-based or clinically appropriate. All management remains pharmacologic and supportive.
Special / Complex Condition Management
- •Urticarial Vasculitis (Confirmed Histopathology)
- *Hydroxychloroquine (200 mg BID):* ¥120–¥200/month →
$17–$28 - *Skin biopsy (incl. histopathology + immunofluorescence):* ¥650 → $92- •
- *IV epinephrine (if admitted):* ¥35 →
$5 - *Hospital observation (12-hour stay):* ¥1,400– → $200–$300Quick Selection Guide
- •
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Urticaria Medical Vacation Packages
Curated transparent all-inclusive packages combining Urticaria treatment with China top medical destinations: